{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:22:50Z","timestamp":1781324570463,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26290041"],"award-info":[{"award-number":["JP26290041"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17H03584"],"award-info":[{"award-number":["JP17H03584"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16K09378"],"award-info":[{"award-number":["JP16K09378"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jikei University Graduate Research Found"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol-Myers Squibb foundation and SGH foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.canlet.2019.02.046","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T11:25:09Z","timestamp":1551871509000},"page":"100-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer"],"prefix":"10.1016","volume":"451","author":[{"given":"Shiho","family":"Yokoyama-Mashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Yogosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Kanegae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saishu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toya","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Yanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunekazu","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3108-7383","authenticated-orcid":false,"given":"Kiyotsugu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.02.046_bib1","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2019.02.046_bib2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.02.046_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2019.02.046_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","article-title":"Obesity, inflammation, and liver cancer","volume":"56","author":"Sun","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2019.02.046_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2019.02.046_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2019.02.046_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial","volume":"57","author":"Bruix","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2019.02.046_bib8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ejca.2011.12.006","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial","volume":"48","author":"Cheng","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2019.02.046_bib9","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jhep.2011.12.009","article-title":"Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses","volume":"56","author":"Raoul","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2019.02.046_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.molcel.2007.02.007","article-title":"DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage","volume":"25","author":"Taira","year":"2007","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2019.02.046_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jmcb\/mjs047","article-title":"Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways","volume":"4","author":"Perez","year":"2012","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2019.02.046_bib12","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1074\/jbc.M109.042341","article-title":"ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage","volume":"285","author":"Taira","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2019.02.046_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI60818","article-title":"DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells","volume":"122","author":"Taira","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2019.02.046_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.canlet.2013.06.005","article-title":"DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail","volume":"339","author":"Mimoto","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.02.046_bib15","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1007\/s13277-015-3264-y","article-title":"DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma","volume":"36","author":"Yamaguchi","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.canlet.2019.02.046_bib16","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1007\/s13277-014-2413-z","article-title":"Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer","volume":"35","author":"Enomoto","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.canlet.2019.02.046_bib17","doi-asserted-by":"crossref","first-page":"e14078","DOI":"10.1371\/journal.pone.0014078","article-title":"Exploring the link between germline and somatic genetic alterations in breast carcinogenesis","volume":"5","author":"Bonifaci","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.02.046_bib18","first-page":"3009","article-title":"A novel near-infrared fluorescent protein, iRFP720, facilitates transcriptional profiling of prostate cancer bone metastasis in mice","volume":"37","author":"Honda","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2019.02.046_bib19","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep.26159","article-title":"Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers","volume":"57","author":"Oikawa","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2019.02.046_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbrc.2011.12.016","article-title":"Copy number of adenoviral vector genome transduced into target cells can be measured using quantitative PCR: application to vector titration","volume":"417","author":"Pei","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2019.02.046_bib21","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/srep01136","article-title":"Efficient production of adenovirus vector lacking genes of virus-associated RNAs that disturb cellular RNAi machinery","volume":"3","author":"Maekawa","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.02.046_bib22","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1073\/pnas.93.3.1320","article-title":"Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome","volume":"93","author":"Miyake","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2019.02.046_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.virusres.2011.05.019","article-title":"Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirus","volume":"160","author":"Chiyo","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.canlet.2019.02.046_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2012.01.146","article-title":"Effect of influenza A virus non-structural protein 1(NS1) on a mouse model of diabetes mellitus induced by Streptozotocin","volume":"419","author":"Pei","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2019.02.046_bib25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/cas.13280","article-title":"Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer","volume":"108","author":"Ito","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2019.02.046_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2011.06.030","article-title":"High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells","volume":"310","author":"Yokomizo","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.02.046_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.prp.2016.01.002","article-title":"Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma","volume":"212","author":"Zhang","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.canlet.2019.02.046_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12894-015-0040-7","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy","volume":"15","author":"Nomura","year":"2015","journal-title":"BMC Urol."},{"key":"10.1016\/j.canlet.2019.02.046_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/hum.2017.203","article-title":"Biology of the adrenal gland cortex obviates effective use of adeno-associated virus vectors to treat hereditary adrenal disorders","volume":"29","author":"Markmann","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.02.046_bib30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/hum.2017.154","article-title":"Synthetic adeno-associated viral vector efficiently targets mouse and nonhuman primate retina in vivo","volume":"29","author":"Carvalho","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.02.046_bib31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1089\/hum.2017.29059.trf","article-title":"Therapeutic advances in Germany and beyond","volume":"28","author":"Flotte","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.02.046_bib32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/hum.2017.163","article-title":"Adeno-associated virus gene therapy in a sheep model of tay-sachs disease","volume":"29","author":"Gray-Edwards","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.02.046_bib33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/hum.2017.120","article-title":"Delivery of adeno-associated virus vectors in adult mammalian inner-ear cell subtypes without auditory dysfunction","volume":"29","author":"Tao","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.02.046_bib34","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1089\/hum.2017.138","article-title":"Virotherapy research in Germany: from engineering to translation","volume":"28","author":"Ungerechts","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.02.046_bib35","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1089\/hum.2017.186","article-title":"p53 plays a key role in the apoptosis of human ovarian cancer cells induced by adenovirus-mediated CRM197","volume":"29","author":"Dai","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.02.046_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/hum.2007.085","article-title":"Expression of pIX gene induced by transgene promoter: possible cause of host immune response in first-generation adenoviral vectors","volume":"18","author":"Nakai","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2019.02.046_bib37","first-page":"2966","article-title":"A dual-regulated oncolytic adenovirus carrying TAp63 gene exerts potent antitumor effect on colorectal cancer cells","volume":"9","author":"Luo","year":"2017","journal-title":"Am. J. Transl. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519301326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519301326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T09:42:07Z","timestamp":1565170927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519301326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"alternative-id":["S0304383519301326"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.02.046","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.02.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}